Abstract:Background: Atopic dermatitis (AD) is a chronic, itchy inflammatory disease that significantly affects quality of life (QoL). Assessing this impact is essential for optimal management.
Objective: The aim of the study was to evaluate the impact of AD on QoL in affected patients and their families.
Methods: We conducted a case–control study at the Monastir Dermatology Department over 4 months (September–December 2022), including 100 patients with the disease and 100 controls. QoL was assessed using Dermatology Life Quality Index (DLQI) (>15 years), Children’s Dermatology Life Quality Index (CDLQI) (5–15 years), IDQOL (<5 years), and Dermatitis Family Impact (DFI) for families.
Results: The median age of patients and controls was 13.5 years, with a female predominance (F/H ratio = 1.32). The median onset age was 5 years. QoL was significantly worse in patients with AD and their families. CDLQI and DLQI showed moderate positive correlations with Scoring Atopic Dermatitis Index (SCORAD) (P = 0.004; r = 0.434 and P = 0.033; r = 0.322), while DFI had a strong correlation (P < 0.001; r = 0.575), reflecting the family burden. Beyond disease severity, QoL was influenced by pruritus intensity, socioeconomic status, environmental factors, and eczema extent, topography, and appearance.
Conclusions: AD significantly impacts patients’ and families’ QoL. Specific QoL assessment scales are essential for optimizing management.
Get full access to this article
View all access options for this article.
References
1.
DeA, KarekarS, AdhavC. Current burden of atopic dermatitis in India: A systematic literature review. Indian J Dermatol. 2023; 68(4):487.
MahfoudhA, ZaraaI, AmaraT, et al.La dermatite atopique sévère de l’enfant. Tunis Med., 2014; 92:249–252.
4.
LifschitzC. The impact of atopic dermatitis on quality of life. Ann Nutr Metab. 2015; 66(Suppl 1):34–40.
5.
EzzedineK, ReguiaiZ, TaiebC, et al.Qualité de vie et fardeau de la dermatite atopique: Une étude française. Rev Epidemiol Sante Publique., 2017; 65(S3):S136.
6.
MorganM, McCreedyR, SimpsonJ, et al.Dermatology quality of life scales–a measure of the impact of skin diseases. Br J Dermatol. 1997; 136(2):202–206.
7.
MounaK, Ben HamoudaM, HichemB, et al.Evaluation of a modified version of the United Kingdom working party diagnostic criteria for atopic dermatitis in Tunisia. Dermatitis. 2022; 33(6S):S119–S123.
8.
GirolomoniG, de Bruin-WellerM, AokiV, et al.Nomenclature and clinical phenotypes of atopic dermatitis. Ther Adv Chronic Dis. 2021; 12:20406223211002979–20406223211002915.
9.
EichenfieldLF, TomWL, ChamlinSL, et al.Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014; 70(2):338–351.
10.
PedersenCJ, UddinMJ, SahaSK, et al.Prevalence and psychosocial impact of atopic dermatitis in Bangladeshi children and families. PLoS One. 2021; 16(4):e0249824.
11.
ChinnDJ, PoynerT, SibleyG. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol. 2002; 146(3):432–439.
12.
Lewis-JonesMS, FinlayAY, DykesPJ. The infants’ dermatitis quality of life index. Br J Dermatol. 2001; 144(1):104–110.
13.
AhmadK, RamsayB. Measuring the impact on quality of life of infants with atopic dermatitis in a dedicated clinic. J Am Acad Dermatol., 2009; 60.
14.
Ražnatović DjurovićM, JankovićJ, CirkovicA, et al.Quality of life in infants with atopic dermatitis and their families. pdia. 2020; 37(1):66–72.
15.
AlzolibaniAA. Impact of atopic dermatitis on the quality of life of Saudi children. Saudi Med J. avr., 2014; 35(4):391–396.
16.
AlvarengaTM, CaldeiraAP. Quality of life in pediatric patients with atopic dermatitis. J Pediatr (Rio J)., 2009; 85(5):415–420.
17.
HonKL, PongNH, PoonTCW, et al.Quality of life and psychosocial issues are important outcome measures in eczema treatment. J Dermatolog Treat. 2015; 26(1):83–89.
18.
LeeS, ShinA. Association of atopic dermatitis with depressive symptoms and suicidal behaviors among adolescents in Korea: The 2013 Korean youth risk behavior survey. BMC Psychiatry. 2017; 17(1):3.
19.
NohHM, ChoJJ, ParkYS, et al.The relationship between suicidal behaviors and atopic dermatitis in Korean adolescents. J Health Psychol. 2016; 21(10):2183–2194.
20.
PatelKR, ImmaneniS, SingamV, et al.Association between atopic dermatitis, depression, and suicidal ideation: A systematic review and meta-analysis. J Am Acad Dermatol. 2019; 80(2):402–410.
21.
TorreloA, OrtizJ, AlomarA, et al.Atopic dermatitis: Impact on quality of life and patients’ attitudes toward its management. Eur J Dermatol. 2012; 22(1):97–105.
22.
Sánchez-PérezJ, Daudén-TelloE, MoraAM, et al.Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: The PSEDA study. Actas Dermosifiliogr. 2013; 104(1):44–52.
23.
MilanesiN, GolaM, CartocciA, et al.Effect of dupilumab on sleep disturbances in adult patients with severe atopic dermatitis. Ital J Dermatol Venerol. 2022; 157(2):142–145.
24.
YanoC, SaekiH, IshijiT, et al.Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis. J Dermatol Sci. 2013; 72(2):195–197.
25.
AziahMS, RosnahT, MardziahA, et al.Childhood atopic dermatitis: A measurement of quality of life and family impact. Med J Malaysia. 2002; 57(3):329–339.
26.
WittCM, BrinkhausB, PachD, et al.Homoeopathic versus conventional therapy for atopic eczema in children: Medical and economic results. Dermatology. 2009; 219(4):329–340.
27.
FivensonD, ArnoldRJG, KanieckiDJ, et al.The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm. 2002; 8(5):333–342.
28.
SuJC, KempAS, VarigosGA, et al.Atopic eczema: Its impact on the family and financial cost. Arch Dis Child. 1997; 76(2):159–162.
29.
LapidusCS, KerrPE. Social impact of atopic dermatitis. Med Health R I. 2001; 84(9):294–295.
30.
SachdevaM, PriceKN, HsiaoJL, et al.Pearls for managing atopic dermatitis in patients with low socioeconomic status. Dermatitis. 2020; 31(5):297–302.
31.
StefanovicN, IrvineAD, FlohrC. The role of the environment and exposome in atopic dermatitis. Curr Treat Options Allergy. 2021; 8(3):222–241.
32.
TanQ, YangH, WangH. Quality of life in children with atopic dermatitis. Zhongguo Dang Dai Er Ke Za Zhi. mai., 2010; 12:351–353.
33.
ChamlinSL, MattsonCL, FriedenIJ, et al.The price of pruritus: Sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med. 2005; 159(8):745–750.
34.
WeberMB, Fontes NetoPdTdL, PratiC, et al.Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol. 2008; 22(8):992–997.
35.
XuX, van GalenLS, KohMJA, et al.Factors influencing quality of life in children with atopic dermatitis and their caregivers: A cross-sectional study. Sci Rep. 2019; 9(1):15990.
36.
PaulC, GriffithsCEM, CostanzoA, et al.Factors predicting quality of life impairment in adult patients with atopic dermatitis: Results from a patient survey and machine learning analysis. Dermatol Ther (Heidelb)., 2023; 13(4):981–995.
37.
SilverbergJI, Chiesa-FuxenchZ, MargolisD, et al.Epidemiology and burden of sleep disturbances in atopic dermatitis in US adults. Dermatitis. 2022; 33(6S):S104–S113.
38.
Al ShobailiHA. The impact of childhood atopic dermatitis on the patients’ family. Pediatr Dermatol. 2010; 27(6):618–623.
39.
CoutanceauC, StalderJF. Analysis of correlations between patient-oriented SCORAD (POSCORAD) and other assessment scores of atopic dermatitis severity and quality of life. Dermatology. 2014; 229(3):248–255.
40.
DodingtonSR, BasraMKA, FinlayAY, et al.The dermatitis family impact questionnaire: A review of its measurement properties and clinical application. Br J Dermatol. 2013; 169(1):31–46.
41.
van ValburgRW, WillemsenMG, Dirven-MeijerPC, et al.Quality of life measurement and its relationship to disease severity in children with atopic dermatitis in general practice. Acta Derm Venereol. 2011; 91(2):147–151.
